Canine
monocytic ehrlichiosis (CME), caused by transmitted Ehrlichia
canis infection, is a major disease in dogs with
worldwide distribution. Herein, a nucleic acid assay was established
for the identification of E. canis infection employing
a fluorescently labeled conformationally constrained pyrrolidinyl
PNA probe (Flu-acpcPNA) designed to sequence-specifically target the
16S rRNA gene. The sensing principle is based on the excellent quenching
ability of graphene oxide (GO) of the free PNA probe, that was diminished
upon binding to the DNA target. The addition of DNase I improved the
performance of the detection system by eliminating the nonspecific
quenching capability of long-chain dsDNA and thus enhancing the fluorescence
signaling. The assay was coupled with a recombinase polymerase amplification
(RPA) technique, which could be performed under isothermal conditions
(37 °C) without DNA denaturation and purification steps. The
established method is simple to set up and execute, proving a rapid,
specific, and sensitive detection of 16S rRNA gene of E. canis with a limit of detection at least 11.1 pM. This technique shows
good potential for the visual detection of double-stranded DNA targets
without the need for PCR or complicated instruments, which shows great
promise for practical usage in resource limited areas.
C2 symmetrical chiral amino alcohol ligands with a central thiophene moiety have shown to be effective in combination with CuCl2 in the asymmetric acylation of dl-hydrobenzoins. In contrast to previously developed chiral ligands, readily available acetyl chloride and acetic anhydride can be used as reagents in addition to the benzoyl chloride giving rise to the corresponding monoacylated products in up to 99 %ee (S = 532).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.